-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S8f2mzfWrJxlsDKgvpm8aVUulRn5fBtCQATPv8Lu4eTSLtEmEtdqm/zTNW1jUuFC W4BXFsoZdWoL1RuoTmy/GQ== 0001140361-09-024149.txt : 20091030 0001140361-09-024149.hdr.sgml : 20091030 20091030144540 ACCESSION NUMBER: 0001140361-09-024149 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090603 FILED AS OF DATE: 20091030 DATE AS OF CHANGE: 20091030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis Katherine Lyon CENTRAL INDEX KEY: 0001399265 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30379 FILM NUMBER: 091147719 MAIL ADDRESS: STREET 1: C/O CHEMBIO DIAGNOSTICS STREET 2: 3661 HORSEBLOCK ROAD CITY: MEDFORD STATE: NY ZIP: 11763 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMBIO DIAGNOSTICS, INC. CENTRAL INDEX KEY: 0001092662 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880425691 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3661 HORSEBLOCK ROAD CITY: MEDFORD STATE: NY ZIP: 11763 BUSINESS PHONE: (631) 924-1135 MAIL ADDRESS: STREET 1: 3661 HORSEBLOCK ROAD CITY: MEDFORD STATE: NY ZIP: 11763 FORMER COMPANY: FORMER CONFORMED NAME: Chembio Diagnostics Inc. DATE OF NAME CHANGE: 20040607 FORMER COMPANY: FORMER CONFORMED NAME: TRADING SOLUTIONS COM INC DATE OF NAME CHANGE: 19990805 4 1 doc1.xml FORM 4 X0303 4 2009-06-03 0 0001092662 CHEMBIO DIAGNOSTICS, INC. CEMI 0001399265 Davis Katherine Lyon 3661 HORSEBLOCK ROAD MEDFORD NY 11763 1 0 0 0 Options (right to buy) .48 2009-06-03 4 D 0 108000 D 2012-06-21 Common Stock 108000 0 D Options (right to buy) .13 2009-06-03 4 A 0 375000 .13 A 2014-06-03 Common Stock 375000 75000 D 36,000 options vested on each of 6/21/09, 6/21/10, and 6/21/11. The reporting person agreed to cancellation of an option granted to her in consideration of a change in director's compensation 75,000 options vested on each of 6/3/09, 6/3/10, 6/3/11, 6/3/12, and 6/3/13 /S/ Katherine L. Davis 2009-10-29 -----END PRIVACY-ENHANCED MESSAGE-----